These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 16444463)

  • 1. The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.
    Fernandez B; Strootman D
    Angiology; 2006; 57(1):99-102. PubMed ID: 16444463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for Buerger's disease.
    Cacione DG; Macedo CR; Baptista-Silva JC
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011033. PubMed ID: 26967103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment for Buerger's disease.
    Cacione DG; Baptista-Silva JC; Macedo CR
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011033. PubMed ID: 26828199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of smokeless tobacco for cigarettes in Buerger's disease does not prevent limb loss.
    Lawrence PF; Lund OI; Jimenez JC; Muttalib R
    J Vasc Surg; 2008 Jul; 48(1):210-2. PubMed ID: 18589234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buerger's disease and protein S deficiency: successful treatment with prostacyclin.
    Athanassiou P; McHale J; Dikeou S; Laffan M; Dantis P; Davies KA
    Clin Exp Rheumatol; 1995; 13(3):371-5. PubMed ID: 7554568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).
    Modaghegh MS; Hafezi S
    Vasc Endovascular Surg; 2018 Feb; 52(2):124-130. PubMed ID: 29237360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease).
    Hooten WM; Bruns HK; Hays JT
    Mayo Clin Proc; 1998 Jun; 73(6):529-32. PubMed ID: 9621859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
    Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Blanco-Sánchez G; Rodríguez-Mateos ME; Linares-Barrios M
    Dermatol Ther; 2015; 28(3):135-9. PubMed ID: 25649782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria of Buerger's disease.
    Shionoya S
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S243-5; discussion S247. PubMed ID: 9951826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery disease in patients with Buerger's disease.
    Hong TE; Faxon DP
    Rev Cardiovasc Med; 2005; 6(4):222-6. PubMed ID: 16379018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thromboangiitis obliterans (Buerger's disease) in 2 women].
    Njo KT; Smit AJ
    Ned Tijdschr Geneeskd; 1996 Aug; 140(35):1770-2. PubMed ID: 8927130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria and treatment of Buerger's disease: a review.
    Lazarides MK; Georgiadis GS; Papas TT; Nikolopoulos ES
    Int J Low Extrem Wounds; 2006 Jun; 5(2):89-95. PubMed ID: 16698911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboangiitis obliterans (Buerger's disease) with intestinal involvement--a case report.
    Núñez Garcia A; López Cubero L; Rico Zalba L; Molíns Otero A; Gómez Octavio J; Arribas A
    Angiology; 1998 Jun; 49(6):489-92. PubMed ID: 9631896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboangiitis obliterans (Buerger's disease).
    Klein-Weigel PF; Richter JG
    Vasa; 2014 Sep; 43(5):337-46. PubMed ID: 25147010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy.
    Mills JL
    Semin Vasc Surg; 2003 Sep; 16(3):179-89. PubMed ID: 12975757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
    Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
    J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease).
    Swigris JJ; Olin JW; Mekhail NA
    J Vasc Surg; 1999 May; 29(5):928-35. PubMed ID: 10231644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular reconstruction in Buerger's disease: is it feasible?
    Dilege S; Aksoy M; Kayabali M; Genc FA; Senturk M; Baktiroglu S
    Surg Today; 2002; 32(12):1042-7. PubMed ID: 12541020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral intestinal Buerger's disease.
    Lie JT
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S249-56. PubMed ID: 9951827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger's disease patients.
    Kacmaz F; Kaya A; Keskin M; Keceoglu S; Algin IH; Yilmazkaya B; Ilkay E
    Vascular; 2019 Jun; 27(3):233-241. PubMed ID: 30305010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.